[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Graves Disease Market - Global Outlook and Forecast 2021-2027

April 2021 | 92 pages | ID: GF00EB66B796EN
Market Monitor Global

US$ 3,250.00

E-mail Delivery (PDF)

Download PDF Leaflet

Wire Transfer
Checkout Later
Need Help? Ask a Question
This report contains market size and forecasts of Graves Disease in Global, including the following market information:

Global Graves Disease Market Revenue, 2016-2021, 2022-2027, ($ millions)

Global top five companies in 2020 (%)

The global Graves Disease market was valued at xx million in 2020 and is projected to reach US$ xx million by 2027, at a CAGR of xx% during the forecast period.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Graves Disease companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Graves Disease Market, By Type, 2016-2021, 2022-2027 ($ millions)

Global Graves Disease Market Segment Percentages, By Type, 2020 (%)
  • Anti-Thyroid Drugs
  • Lodine &Lodides
  • Radioactive Lodine
  • Lonic Inhibitors
China Graves Disease Market, By Application, 2016-2021, 2022-2027 ($ millions)

China Graves Disease Market Segment Percentages, By Application, 2020 (%)
  • Hospital Pharmacy
  • Online Pharmacy
  • Retail Pharmacy
Global Graves Disease Market, By Region and Country, 2016-2021, 2022-2027 ($ Millions)

Global Graves Disease Market Segment Percentages, By Region and Country, 2020 (%)
  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Russia
    • Nordic Countries
    • Benelux
    • Rest of Europe
  • Asia
    • China
    • Japan
    • South Korea
    • Southeast Asia
    • India
    • Rest of Asia
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Middle East & Africa
    • Turkey
    • Israel
    • Saudi Arabia
    • UAE
    • Rest of Middle East & Africa
Competitor Analysis

The report also provides analysis of leading market participants including:

Total Graves Disease Market Competitors Revenues in Global, by Players 2016-2021 (Estimated), ($ millions)

Total Graves Disease Market Competitors Revenues Share in Global, by Players 2020 (%)

Further, the report presents profiles of competitors in the market, including the following:
  • Abbott Laboratories
  • GlaxoSmithKline plc
  • Merck & Co
  • Pfizer, Inc
  • RLC LABS
  • AbbVie, Inc
  • Mylan N.V
  • Allergan, plc
1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Graves Disease Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Graves Disease Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL GRAVES DISEASE OVERALL MARKET SIZE

2.1 Global Graves Disease Market Size: 2021 VS 2027
2.2 Global Graves Disease Market Size, Prospects & Forecasts: 2016-2027
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Graves Disease Players in Global Market
3.2 Top Global Graves Disease Companies Ranked by Revenue
3.3 Global Graves Disease Revenue by Companies
3.4 Top 3 and Top 5 Graves Disease Companies in Global Market, by Revenue in 2020
3.5 Global Companies Graves Disease Product Type
3.6 Tier 1, Tier 2 and Tier 3 Graves Disease Players in Global Market
  3.6.1 List of Global Tier 1 Graves Disease Companies
  3.6.2 List of Global Tier 2 and Tier 3 Graves Disease Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 By Type - Global Graves Disease Market Size Markets, 2021 & 2027
  4.1.2 Anti-Thyroid Drugs
  4.1.3 Lodine &Lodides
  4.1.4 Radioactive Lodine
  4.1.5 Lonic Inhibitors
4.2 By Type - Global Graves Disease Revenue & Forecasts
  4.2.1 By Type - Global Graves Disease Revenue, 2016-2021
  4.2.2 By Type - Global Graves Disease Revenue, 2022-2027
  4.2.3 By Type - Global Graves Disease Revenue Market Share, 2016-2027

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Graves Disease Market Size, 2021 & 2027
  5.1.2 Hospital Pharmacy
  5.1.3 Online Pharmacy
  5.1.4 Retail Pharmacy
5.2 By Application - Global Graves Disease Revenue & Forecasts
  5.2.1 By Application - Global Graves Disease Revenue, 2016-2021
  5.2.2 By Application - Global Graves Disease Revenue, 2022-2027
  5.2.3 By Application - Global Graves Disease Revenue Market Share, 2016-2027

6 SIGHTS BY REGION

6.1 By Region - Global Graves Disease Market Size, 2021 & 2027
6.2 By Region - Global Graves Disease Revenue & Forecasts
  6.2.1 By Region - Global Graves Disease Revenue, 2016-2021
  6.2.2 By Region - Global Graves Disease Revenue, 2022-2027
  6.2.3 By Region - Global Graves Disease Revenue Market Share, 2016-2027
6.3 North America
  6.3.1 By Country - North America Graves Disease Revenue, 2016-2027
  6.3.2 US Graves Disease Market Size, 2016-2027
  6.3.3 Canada Graves Disease Market Size, 2016-2027
  6.3.4 Mexico Graves Disease Market Size, 2016-2027
6.4 Europe
  6.4.1 By Country - Europe Graves Disease Revenue, 2016-2027
  6.4.2 Germany Graves Disease Market Size, 2016-2027
  6.4.3 France Graves Disease Market Size, 2016-2027
  6.4.4 U.K. Graves Disease Market Size, 2016-2027
  6.4.5 Italy Graves Disease Market Size, 2016-2027
  6.4.6 Russia Graves Disease Market Size, 2016-2027
  6.4.7 Nordic Countries Graves Disease Market Size, 2016-2027
  6.4.8 Benelux Graves Disease Market Size, 2016-2027
6.5 Asia
  6.5.1 By Region - Asia Graves Disease Revenue, 2016-2027
  6.5.2 China Graves Disease Market Size, 2016-2027
  6.5.3 Japan Graves Disease Market Size, 2016-2027
  6.5.4 South Korea Graves Disease Market Size, 2016-2027
  6.5.5 Southeast Asia Graves Disease Market Size, 2016-2027
  6.5.6 India Graves Disease Market Size, 2016-2027
6.6 South America
  6.6.1 By Country - South America Graves Disease Revenue, 2016-2027
  6.6.2 Brazil Graves Disease Market Size, 2016-2027
  6.6.3 Argentina Graves Disease Market Size, 2016-2027
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Graves Disease Revenue, 2016-2027
  6.7.2 Turkey Graves Disease Market Size, 2016-2027
  6.7.3 Israel Graves Disease Market Size, 2016-2027
  6.7.4 Saudi Arabia Graves Disease Market Size, 2016-2027
  6.7.5 UAE Graves Disease Market Size, 2016-2027

7 PLAYERS PROFILES

7.1 Abbott Laboratories
  7.1.1 Abbott Laboratories Corporate Summary
  7.1.2 Abbott Laboratories Business Overview
  7.1.3 Abbott Laboratories Graves Disease Major Product Offerings
  7.1.4 Abbott Laboratories Graves Disease Revenue in Global (2016-2021)
  7.1.5 Abbott Laboratories Key News
7.2 GlaxoSmithKline plc
  7.2.1 GlaxoSmithKline plc Corporate Summary
  7.2.2 GlaxoSmithKline plc Business Overview
  7.2.3 GlaxoSmithKline plc Graves Disease Major Product Offerings
  7.2.4 GlaxoSmithKline plc Graves Disease Revenue in Global (2016-2021)
  7.2.5 GlaxoSmithKline plc Key News
7.3 Merck & Co
  7.3.1 Merck & Co Corporate Summary
  7.3.2 Merck & Co Business Overview
  7.3.3 Merck & Co Graves Disease Major Product Offerings
  7.3.4 Merck & Co Graves Disease Revenue in Global (2016-2021)
  7.3.5 Merck & Co Key News
7.4 Pfizer, Inc
  7.4.1 Pfizer, Inc Corporate Summary
  7.4.2 Pfizer, Inc Business Overview
  7.4.3 Pfizer, Inc Graves Disease Major Product Offerings
  7.4.4 Pfizer, Inc Graves Disease Revenue in Global (2016-2021)
  7.4.5 Pfizer, Inc Key News
7.5 RLC LABS
  7.5.1 RLC LABS Corporate Summary
  7.5.2 RLC LABS Business Overview
  7.5.3 RLC LABS Graves Disease Major Product Offerings
  7.5.4 RLC LABS Graves Disease Revenue in Global (2016-2021)
  7.5.5 RLC LABS Key News
7.6 AbbVie, Inc
  7.6.1 AbbVie, Inc Corporate Summary
  7.6.2 AbbVie, Inc Business Overview
  7.6.3 AbbVie, Inc Graves Disease Major Product Offerings
  7.6.4 AbbVie, Inc Graves Disease Revenue in Global (2016-2021)
  7.6.5 AbbVie, Inc Key News
7.7 Mylan N.V
  7.7.1 Mylan N.V Corporate Summary
  7.7.2 Mylan N.V Business Overview
  7.7.3 Mylan N.V Graves Disease Major Product Offerings
  7.4.4 Mylan N.V Graves Disease Revenue in Global (2016-2021)
  7.7.5 Mylan N.V Key News
7.8 Allergan, plc
  7.8.1 Allergan, plc Corporate Summary
  7.8.2 Allergan, plc Business Overview
  7.8.3 Allergan, plc Graves Disease Major Product Offerings
  7.8.4 Allergan, plc Graves Disease Revenue in Global (2016-2021)
  7.8.5 Allergan, plc Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES

Table 1. Graves Disease Market Opportunities & Trends in Global Market
Table 2. Graves Disease Market Drivers in Global Market
Table 3. Graves Disease Market Restraints in Global Market
Table 4. Key Players of Graves Disease in Global Market
Table 5. Top Graves Disease Players in Global Market, Ranking by Revenue (2019)
Table 6. Global Graves Disease Revenue by Companies, (US$, Mn), 2016-2021
Table 7. Global Graves Disease Revenue Share by Companies, 2016-2021
Table 8. Global Companies Graves Disease Product Type
Table 9. List of Global Tier 1 Graves Disease Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Graves Disease Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. By Type – Global Graves Disease Revenue, (US$, Mn), 2021 VS 2027
Table 12. By Type - Graves Disease Revenue in Global (US$, Mn), 2016-2021
Table 13. By Type - Graves Disease Revenue in Global (US$, Mn), 2022-2027
Table 14. By Application – Global Graves Disease Revenue, (US$, Mn), 2021 VS 2027
Table 15. By Application - Graves Disease Revenue in Global (US$, Mn), 2016-2021
Table 16. By Application - Graves Disease Revenue in Global (US$, Mn), 2022-2027
Table 17. By Region – Global Graves Disease Revenue, (US$, Mn), 2021 VS 2027
Table 18. By Region - Global Graves Disease Revenue (US$, Mn), 2016-2021
Table 19. By Region - Global Graves Disease Revenue (US$, Mn), 2022-2027
Table 20. By Country - North America Graves Disease Revenue, (US$, Mn), 2016-2021
Table 21. By Country - North America Graves Disease Revenue, (US$, Mn), 2022-2027
Table 22. By Country - Europe Graves Disease Revenue, (US$, Mn), 2016-2021
Table 23. By Country - Europe Graves Disease Revenue, (US$, Mn), 2022-2027
Table 24. By Region - Asia Graves Disease Revenue, (US$, Mn), 2016-2021
Table 25. By Region - Asia Graves Disease Revenue, (US$, Mn), 2022-2027
Table 26. By Country - South America Graves Disease Revenue, (US$, Mn), 2016-2021
Table 27. By Country - South America Graves Disease Revenue, (US$, Mn), 2022-2027
Table 28. By Country - Middle East & Africa Graves Disease Revenue, (US$, Mn), 2016-2021
Table 29. By Country - Middle East & Africa Graves Disease Revenue, (US$, Mn), 2022-2027
Table 30. Abbott Laboratories Corporate Summary
Table 31. Abbott Laboratories Graves Disease Product Offerings
Table 32. Abbott Laboratories Graves Disease Revenue (US$, Mn), (2016-2021)
Table 33. GlaxoSmithKline plc Corporate Summary
Table 34. GlaxoSmithKline plc Graves Disease Product Offerings
Table 35. GlaxoSmithKline plc Graves Disease Revenue (US$, Mn), (2016-2021)
Table 36. Merck & Co Corporate Summary
Table 37. Merck & Co Graves Disease Product Offerings
Table 38. Merck & Co Graves Disease Revenue (US$, Mn), (2016-2021)
Table 39. Pfizer, Inc Corporate Summary
Table 40. Pfizer, Inc Graves Disease Product Offerings
Table 41. Pfizer, Inc Graves Disease Revenue (US$, Mn), (2016-2021)
Table 42. RLC LABS Corporate Summary
Table 43. RLC LABS Graves Disease Product Offerings
Table 44. RLC LABS Graves Disease Revenue (US$, Mn), (2016-2021)
Table 45. AbbVie, Inc Corporate Summary
Table 46. AbbVie, Inc Graves Disease Product Offerings
Table 47. AbbVie, Inc Graves Disease Revenue (US$, Mn), (2016-2021)
Table 48. Mylan N.V Corporate Summary
Table 49. Mylan N.V Graves Disease Product Offerings
Table 50. Mylan N.V Graves Disease Revenue (US$, Mn), (2016-2021)
Table 51. Allergan, plc Corporate Summary
Table 52. Allergan, plc Graves Disease Product Offerings
Table 53. Allergan, plc Graves Disease Revenue (US$, Mn), (2016-2021)

LIST OF FIGURES

Figure 1. Graves Disease Segment by Type
Figure 2. Graves Disease Segment by Application
Figure 3. Global Graves Disease Market Overview: 2020
Figure 4. Key Caveats
Figure 5. Global Graves Disease Market Size: 2021 VS 2027 (US$, Mn)
Figure 6. Global Graves Disease Revenue, 2016-2027 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Graves Disease Revenue in 2020
Figure 8. By Type - Global Graves Disease Revenue Market Share, 2016-2027
Figure 9. By Application - Global Graves Disease Revenue Market Share, 2016-2027
Figure 10. By Region - Global Graves Disease Revenue Market Share, 2016-2027
Figure 11. By Country - North America Graves Disease Revenue Market Share, 2016-2027
Figure 12. US Graves Disease Revenue, (US$, Mn), 2016-2027
Figure 13. Canada Graves Disease Revenue, (US$, Mn), 2016-2027
Figure 14. Mexico Graves Disease Revenue, (US$, Mn), 2016-2027
Figure 15. By Country - Europe Graves Disease Revenue Market Share, 2016-2027
Figure 16. Germany Graves Disease Revenue, (US$, Mn), 2016-2027
Figure 17. France Graves Disease Revenue, (US$, Mn), 2016-2027
Figure 18. U.K. Graves Disease Revenue, (US$, Mn), 2016-2027
Figure 19. Italy Graves Disease Revenue, (US$, Mn), 2016-2027
Figure 20. Russia Graves Disease Revenue, (US$, Mn), 2016-2027
Figure 21. Nordic Countries Graves Disease Revenue, (US$, Mn), 2016-2027
Figure 22. Benelux Graves Disease Revenue, (US$, Mn), 2016-2027
Figure 23. By Region - Asia Graves Disease Revenue Market Share, 2016-2027
Figure 24. China Graves Disease Revenue, (US$, Mn), 2016-2027
Figure 25. Japan Graves Disease Revenue, (US$, Mn), 2016-2027
Figure 26. South Korea Graves Disease Revenue, (US$, Mn), 2016-2027
Figure 27. Southeast Asia Graves Disease Revenue, (US$, Mn), 2016-2027
Figure 28. India Graves Disease Revenue, (US$, Mn), 2016-2027
Figure 29. By Country - South America Graves Disease Revenue Market Share, 2016-2027
Figure 30. Brazil Graves Disease Revenue, (US$, Mn), 2016-2027
Figure 31. Argentina Graves Disease Revenue, (US$, Mn), 2016-2027
Figure 32. By Country - Middle East & Africa Graves Disease Revenue Market Share, 2016-2027
Figure 33. Turkey Graves Disease Revenue, (US$, Mn), 2016-2027
Figure 34. Israel Graves Disease Revenue, (US$, Mn), 2016-2027
Figure 35. Saudi Arabia Graves Disease Revenue, (US$, Mn), 2016-2027
Figure 36. UAE Graves Disease Revenue, (US$, Mn), 2016-2027
Figure 37. Abbott Laboratories Graves Disease Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 38. GlaxoSmithKline plc Graves Disease Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 39. Merck & Co Graves Disease Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 40. Pfizer, Inc Graves Disease Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 41. RLC LABS Graves Disease Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 42. AbbVie, Inc Graves Disease Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 43. Mylan N.V Graves Disease Revenue Year Over Year Growth (US$, Mn) & (2016-2021)


More Publications